A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse

Hepatology

Volumn 41, Issue 4, 2005, Pages 887-895

  Roy, Suheeta ^a   Hyogo, Hideyuki ^a   Yadav, Suresh K ^a   Wu, Michele K ^a   Jelicks, Linda A ^a   Locker, Joseph D ^a   Frank, Philippe G ^a   Lisanti, Michael P ^a   Silver, David L ^b   Cohen, David E ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ACYL COENZYME A DESATURASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BILE SALT; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; COMPLEMENTARY DNA; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LEPTIN; LIPID; MESSENGER RNA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; BILE SECRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; DIETARY INTAKE; ENZYME ACTIVITY; FAT INTAKE; HEPATOBILIARY SYSTEM; HORMONE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; BILE; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL, HDL; DIET; DIETARY FATS; DOWN-REGULATION; DRUG RESISTANCE; FATTY ACID SYNTHETASE COMPLEX; HYPERCHOLESTEROLEMIA; ISOENZYMES; LEPTIN; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; OBESITY; STEAROYL-COA DESATURASE;

EID: 20144386690     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20643     Document Type: Article

References (46)

1. Tall AR, Wang N, Mucksavage P. Is it time to modify the reverse cholesterol transport model? J Clin Invest 2001;108:1273-1275.
2. Cohen DE. Pathogenesis of gallstones. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. 4th ed. Philadelphia: W.B. Saunders, 2002:1713-1743.
3. Silver DL, Jiang XC, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 1999;274:4140-4146.
4. Silver DL, Wang N, Xiao X, Tall AR. HDL particle uptake mediated by SR-BI results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 2001;276:25287-25293.
5. VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol 2001;281:G393-G404.
6. Hyogo H, Roy S, Paigen B, Cohen DE. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 2002;277:34117-34124.
7. Vanpatten S, Karkanias GB, Rossetti L, Cohen DE. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J 2004;379:229-233.
8. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
9. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
10. West DB, Boozer CN, Moody DL, Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992;262:R1025-R1032.
11. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995;1:1311-1314.
12. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, et al. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 2002;277:8635-8647.
13. Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R, Somerharju P. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J Lipid Res 2001;42:663-672.
14. Parks JS, Li H, Gebre AK, Smith TL, Maeda N. Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma. J Lipid Res 1995;36:349-355.
15. Sun Y, Hao M, Luo Y, Liang CP, Silver DL, Cheng C, et al. Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J Biol Chem 2003;278:5813-5820.
16. Yang J, Goldstein JL, Hammer RE, Moon YA, Brown MS, Horton JD. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc Natl Acad Sci U S A 2001;98:13607-13612.
17. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997;99:385-390.
18. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002;297:240-243.
19. Fukuda H, Iritani N, Sugimoto T, Ikeda H. Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats. Eur J Biochem 1999;260:505-511.
20. Kaser S, Foger B, Ebenbichler CF, Kirchmair R, Gander R, Ritsch A, et al. Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2. Int J Obes Relat Metab Disord 2001;25:1633-1639.
21. Rigotti A, Trigatti B, Babitt J, Penman M, Xu S, Krieger M. Scavenger receptor BI-a cell surface receptor for high density lipoprotein. Curr Opin Lipidol 1997;8:181-188.
22. 1 cholesteryl ester in the rat. Effect of ethinyl estradiol treatment. C R Acad Sci III 1999;322:591-596.
23. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989;30:719-730.
24. Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem 2003;278:43224-43228.
25. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000;105:1827-1832.
26. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57B1/6J mice. Int J Obes Relat Metab Disord 2000;24:639-646.
27. Banks WA, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab 2003;285:E10-E15.
28. Basso F, Freeman L, Knapper CL, Remaley A, Stonik J, Neufeld EB, et al. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res 2003;44:296-302.
29. Srivastava RA. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism. Biochem Mol Biol Int 1994;34:393-402.
30. Silver DL, Wang N, Tall AR. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest 2000;105:151-159.
31. Jin W, Marchadier D, Rader DJ. Lipases and HDL metabolism. Trends Endocrinol Metab 2002;13:174-178.
32. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999;103:907-914.
33. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001;294:1866-1870.
34. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Nad Acad Sci U S A 2002;99:16237-16242.
35. Stone BG, Erickson SK, Craig WY, Cooper AD. Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism. Evidence for a distinct biliary precursor pool. J Clin Invest 1985;76:1773-1781.
36. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002;110:671-680.
37. de Silva HV, Mas-Oliva J, Taylor JM, Mahley RW. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J Lipid Res 1994;35:1297-1310.
38. Cao G, Beyer TP, Yang XP, Schmidt RJ, Zhang Y, Bensch WR, et al. Phospholipid transfer protein is regulated by liver X receptors in vivo. J Biol Chem 2002;277:39561-39565.
39. Vaisman BL, Klein HG, Rouis M, Berard AM, Kindt MR, Talley GD, et al. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J Biol Chem 1995;270:12269-12275.
40. Murdoch SJ, Kahn SE, Albers JJ, Brunzell JD, Purnell JQ. PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity. J Lipid Res 2003;44:1705-1712.
41. von Schenck H, Wallentin L, Lennmarken C, Larsson J. Lipoprotein metabolism following gastroplasty in obese women. Scand J Clin Lab Invest 1992;52:269-274.
42. Lin RC. Serum cholesterol, lecithin-cholesterol acyltransferase, and hepatic hydroxymethylglutaryl coenzyme A reductase activities of lean and obese Zucker rats. Metabolism 1985;34:19-24.
43. Homanics GE, de Silva HV, Osada J, Zhang SH, Wong H, Borensztajn J, et al. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem 1995;270:2974-2980.
44. Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem 2001;276:49066-49076.
45. Stahlberg D, Rudling M, Angelin B, Bjorkhem I, Forsell P, Nilsell K, et al. Hepatic cholesterol metabolism in human obesity. HEPATOLOGY 1997;25:1447-1450.
46. Paigen B, Carey MC. Gallstones. In: King RA, Rotter JI, Motulsky AG, eds. The Genetic Basis of Common Diseases. 2nd ed. Oxford, UK: Oxford University Press, 2002:298-335.